Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2008

Open Access 01-12-2008 | Research article

Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population

Authors: Silvia R Freitas, Alexandre C Pereira, Marcilene S Floriano, José G Mill, José E Krieger

Published in: BMC Cardiovascular Disorders | Issue 1/2008

Login to get access

Abstract

Background

The alpha1A-adrenergic receptor (α1A-AR) regulates the cardiac and peripheral vascular system through sympathetic activation. Due to its important role in the regulation of vascular tone and blood pressure, we aimed to investigate the association between the Arg347Cys polymorphism in the α1A-AR gene and blood pressure phenotypes, in a large sample of Brazilians from an urban population.

Methods

A total of 1568 individuals were randomly selected from the general population of the Vitória City metropolitan area. Genetic analysis of the Arg347Cys polymorphism was conducted by polymerase chain reaction/restriction fragment length polymorphism. We have compared cardiovascular risk variables and genotypes using ANOVA, and Chi-square test for univariate comparisons and logistic regression for multivariate comparisons.

Results

Association analysis indicated a significant difference between genotype groups with respect to diastolic blood pressure (p = 0.04), but not systolic blood pressure (p = 0.12). In addition, presence of the Cys/Cys genotype was marginally associated with hypertension in our population (p = 0.06). Significant interaction effects were observed between the studied genetic variant, age and physical activity. Presence of the Cys/Cys genotype was associated with hypertension only in individuals with regular physical activity (odds ratio = 1.86; p = 0.03) or younger than 45 years (odds ratio = 1.27; p = 0.04).

Conclusion

Physical activity and age may potentially play a role by disclosing the effects of the Cys allele on blood pressure. According to our data it is possible that the Arg347Cys polymorphism can be used as a biomarker to disease risk in a selected group of individuals.
Appendix
Available only for authorised users
Literature
1.
go back to reference He J, Whelton PK: Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J. 1999, 138 (3 Pt 2): 211-219. 10.1016/S0002-8703(99)70312-1.CrossRefPubMed He J, Whelton PK: Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J. 1999, 138 (3 Pt 2): 211-219. 10.1016/S0002-8703(99)70312-1.CrossRefPubMed
2.
go back to reference Kannel WB: Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000, 85 (2): 251-255. 10.1016/S0002-9149(99)00635-9.CrossRefPubMed Kannel WB: Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000, 85 (2): 251-255. 10.1016/S0002-9149(99)00635-9.CrossRefPubMed
3.
go back to reference Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell. 2001, 104 (4): 545-556. 10.1016/S0092-8674(01)00241-0.CrossRefPubMed Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell. 2001, 104 (4): 545-556. 10.1016/S0092-8674(01)00241-0.CrossRefPubMed
4.
go back to reference Gu C, Borecki I, Gagnon J, Bouchard C, Leon AS, Skinner JS, Wilmore JH, Rao DC: Familial resemblance for resting blood pressure with particular reference to racial differences: preliminary analyses from the HERITAGE Family Study. Hum Biol. 1998, 70 (1): 77-90.PubMed Gu C, Borecki I, Gagnon J, Bouchard C, Leon AS, Skinner JS, Wilmore JH, Rao DC: Familial resemblance for resting blood pressure with particular reference to racial differences: preliminary analyses from the HERITAGE Family Study. Hum Biol. 1998, 70 (1): 77-90.PubMed
5.
go back to reference Rotimi CN, Cooper RS, Cao G, Ogunbiyi O, Ladipo M, Owoaje E, Ward R: Maximum-likelihood generalized heritability estimate for blood pressure in Nigerian families. Hypertension. 1999, 33 (3): 874-878.CrossRefPubMed Rotimi CN, Cooper RS, Cao G, Ogunbiyi O, Ladipo M, Owoaje E, Ward R: Maximum-likelihood generalized heritability estimate for blood pressure in Nigerian families. Hypertension. 1999, 33 (3): 874-878.CrossRefPubMed
6.
go back to reference Rudner XL, Berkowitz DE, Booth JV, Funk BL, Cozart KL, D'Amico EB, El-Moalem H, Page SO, Richardson CD, Winters B, et al: Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation. 1999, 100 (23): 2336-2343.CrossRefPubMed Rudner XL, Berkowitz DE, Booth JV, Funk BL, Cozart KL, D'Amico EB, El-Moalem H, Page SO, Richardson CD, Winters B, et al: Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation. 1999, 100 (23): 2336-2343.CrossRefPubMed
7.
go back to reference Hoehe MRBWH, Schwinn DA, Hsieh W-T: A two-allele PstI RFLP for the alpha-1C adrenergic receptor gene (ADRA1C). Hum Mol Genet. 1992, 1 (5): 349-10.1093/hmg/1.5.349-a.CrossRefPubMed Hoehe MRBWH, Schwinn DA, Hsieh W-T: A two-allele PstI RFLP for the alpha-1C adrenergic receptor gene (ADRA1C). Hum Mol Genet. 1992, 1 (5): 349-10.1093/hmg/1.5.349-a.CrossRefPubMed
8.
go back to reference Shibata K, Hirasawa A, Moriyama N, Kawabe K, Ogawa S, Tsujimoto G: Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br J Pharmacol. 1996, 118 (6): 1403-1408.CrossRefPubMedPubMedCentral Shibata K, Hirasawa A, Moriyama N, Kawabe K, Ogawa S, Tsujimoto G: Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br J Pharmacol. 1996, 118 (6): 1403-1408.CrossRefPubMedPubMedCentral
9.
go back to reference Xie HG, Kim RB, Stein CM, Gainer JV, Brown NJ, Wood AJ: Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension. Pharmacogenetics. 1999, 9 (5): 651-656. 10.1097/00008571-199910000-00012.PubMed Xie HG, Kim RB, Stein CM, Gainer JV, Brown NJ, Wood AJ: Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension. Pharmacogenetics. 1999, 9 (5): 651-656. 10.1097/00008571-199910000-00012.PubMed
10.
go back to reference Gu DGD, Snieder H, He J, Chen S, Huang J, Li B, Chen R, Quiang B: Association of alpha1A adrenergic receptor gene variants on chromosome 8q21 with human stage 2 hypertension. J Hypertension. 2006, 24: 1049-1056.CrossRef Gu DGD, Snieder H, He J, Chen S, Huang J, Li B, Chen R, Quiang B: Association of alpha1A adrenergic receptor gene variants on chromosome 8q21 with human stage 2 hypertension. J Hypertension. 2006, 24: 1049-1056.CrossRef
11.
go back to reference Jiang S, Mao G, Zhang S, Hong X, Tang G, Li Z, Liu X, Zhang Y, Wang B, Xu X, et al: Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects. Clin Pharmacol Ther. 2005, 78 (3): 239-248. 10.1016/j.clpt.2005.06.003.CrossRefPubMed Jiang S, Mao G, Zhang S, Hong X, Tang G, Li Z, Liu X, Zhang Y, Wang B, Xu X, et al: Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects. Clin Pharmacol Ther. 2005, 78 (3): 239-248. 10.1016/j.clpt.2005.06.003.CrossRefPubMed
12.
go back to reference The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988, 41 (2): 105-114. 10.1016/0895-4356(88)90084-4. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988, 41 (2): 105-114. 10.1016/0895-4356(88)90084-4.
13.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report[see comment][erratum appears in JAMA. 2003 Jul 9;290(2):197]. JAMA. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report[see comment][erratum appears in JAMA. 2003 Jul 9;290(2):197]. JAMA. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed
14.
go back to reference Lessa I, Fonseca J: Raca, aderencia ao tratamento e/ou consultas e controle da hipertensao arterial. Arquivos Brasileiros de Cardiologia. 1997, 68 (6): 443-449.PubMed Lessa I, Fonseca J: Raca, aderencia ao tratamento e/ou consultas e controle da hipertensao arterial. Arquivos Brasileiros de Cardiologia. 1997, 68 (6): 443-449.PubMed
16.
go back to reference Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285 (19): 2486-2497. 10.1001/jama.285.19.2486. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285 (19): 2486-2497. 10.1001/jama.285.19.2486.
17.
go back to reference Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 1988, 16 (3): 1215-10.1093/nar/16.3.1215.CrossRefPubMedPubMedCentral Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 1988, 16 (3): 1215-10.1093/nar/16.3.1215.CrossRefPubMedPubMedCentral
18.
go back to reference Mochtar CA, Laan W, Van Houwelingen KP, Franke B, De La Rosette JJ, Schalken JA, Kiemeney LA: Polymorphisms in the alpha1A-adrenoceptor gene do not modify the short- and long-term efficacy of alpha1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. BJU Int. 2006, 97 (4): 852-855. 10.1111/j.1464-410X.2006.05998.x.CrossRefPubMed Mochtar CA, Laan W, Van Houwelingen KP, Franke B, De La Rosette JJ, Schalken JA, Kiemeney LA: Polymorphisms in the alpha1A-adrenoceptor gene do not modify the short- and long-term efficacy of alpha1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. BJU Int. 2006, 97 (4): 852-855. 10.1111/j.1464-410X.2006.05998.x.CrossRefPubMed
19.
go back to reference Lei B, Morris DP, Smith MP, Svetkey LP, Newman MF, Rotter JI, Buchanan TA, Beckstrom-Sternberg SM, Green ED, Schwinn DA: Novel human alpha1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function. Naunyn Schmiedebergs Arch Pharmacol. 2005, 371 (3): 229-239. 10.1007/s00210-005-1019-9.CrossRefPubMedPubMedCentral Lei B, Morris DP, Smith MP, Svetkey LP, Newman MF, Rotter JI, Buchanan TA, Beckstrom-Sternberg SM, Green ED, Schwinn DA: Novel human alpha1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function. Naunyn Schmiedebergs Arch Pharmacol. 2005, 371 (3): 229-239. 10.1007/s00210-005-1019-9.CrossRefPubMedPubMedCentral
20.
go back to reference Rokosh DG, Simpson PC: Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA. 2002, 99 (14): 9474-9479. 10.1073/pnas.132552699.CrossRefPubMedPubMedCentral Rokosh DG, Simpson PC: Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA. 2002, 99 (14): 9474-9479. 10.1073/pnas.132552699.CrossRefPubMedPubMedCentral
21.
go back to reference Hsu JW, Wang YC, Lin CC, Bai YM, Chen JY, Chiu HJ, Tsai SJ, Hong CJ: No evidence for association of alpha 1a adrenoceptor gene polymorphism and clozapine-induced urinary incontinence. Neuropsychobiology. 2000, 42 (2): 62-65. 10.1159/000026674.CrossRefPubMed Hsu JW, Wang YC, Lin CC, Bai YM, Chen JY, Chiu HJ, Tsai SJ, Hong CJ: No evidence for association of alpha 1a adrenoceptor gene polymorphism and clozapine-induced urinary incontinence. Neuropsychobiology. 2000, 42 (2): 62-65. 10.1159/000026674.CrossRefPubMed
22.
go back to reference Snapir A, Koskenvuo J, Toikka J, Orho-Melander M, Hinkka S, Saraste M, Hartiala J, Scheinin M: Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline. Clinical Science. 2003, 104 (5): 509-520. 10.1042/CS20020299.CrossRefPubMed Snapir A, Koskenvuo J, Toikka J, Orho-Melander M, Hinkka S, Saraste M, Hartiala J, Scheinin M: Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline. Clinical Science. 2003, 104 (5): 509-520. 10.1042/CS20020299.CrossRefPubMed
23.
go back to reference Iacoviello M, Forleo C, Sorrentino S, Romito R, De Tommasi E, Lucarelli K, Guida P, Pitzalis MV: Alpha- and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring. Journal of Cardiovascular Medicine. 2006, 7 (5): 316-321.CrossRefPubMed Iacoviello M, Forleo C, Sorrentino S, Romito R, De Tommasi E, Lucarelli K, Guida P, Pitzalis MV: Alpha- and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring. Journal of Cardiovascular Medicine. 2006, 7 (5): 316-321.CrossRefPubMed
24.
go back to reference Ohyanagi M, Faber JE, Nishigaki K: Differential activation of alpha 1- and alpha 2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation. Circ Res. 1991, 68 (1): 232-244.CrossRefPubMed Ohyanagi M, Faber JE, Nishigaki K: Differential activation of alpha 1- and alpha 2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation. Circ Res. 1991, 68 (1): 232-244.CrossRefPubMed
25.
go back to reference Buckwalter JB, Clifford PS: alpha-adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. Am J Physiol. 1999, 277 (1 Pt 2): H33-39.PubMed Buckwalter JB, Clifford PS: alpha-adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. Am J Physiol. 1999, 277 (1 Pt 2): H33-39.PubMed
26.
go back to reference Rao SP, Collins HL, DiCarlo SE: Postexercise alpha-adrenergic receptor hyporesponsiveness in hypertensive rats is due to nitric oxide. Am J Physiol Regul Integr Comp Physiol. 2002, 282 (4): R960-968.CrossRefPubMed Rao SP, Collins HL, DiCarlo SE: Postexercise alpha-adrenergic receptor hyporesponsiveness in hypertensive rats is due to nitric oxide. Am J Physiol Regul Integr Comp Physiol. 2002, 282 (4): R960-968.CrossRefPubMed
Metadata
Title
Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population
Authors
Silvia R Freitas
Alexandre C Pereira
Marcilene S Floriano
José G Mill
José E Krieger
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2008
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-8-40

Other articles of this Issue 1/2008

BMC Cardiovascular Disorders 1/2008 Go to the issue